Related Experiment Video
Updated: Aug 23, 2026

04:11
A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
Published on: June 9, 2026
Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene
1Huntington Memorial Hospital, Pasadena, CA, USA. mmehlmauermd@earthlink.net
Cutis
|July 1, 2004
Abstract:
Cutaneous T-cell lymphomas (CTCL) encompass a spectrum of clinical and histologic variants, characterized by malignant CD4+ T lymphocytes in the skin and visceral organs. This is a case report of a 74-year-old man with CTCL, including ulcerative lesions, resistant to multiple systemic therapies. Treatment with oral bexarotene resulted in rapid and sustained remission of both cutaneous and systemic symptoms.